...
首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Microfluidic direct injection method for analysis of urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) using molecularly imprinted polymers coupled on-line with LC-MS/MS.
【24h】

Microfluidic direct injection method for analysis of urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) using molecularly imprinted polymers coupled on-line with LC-MS/MS.

机译:微流控直接进样方法通过分子印迹聚合物与LC-MS / MS在线耦合分析尿中的4-(甲基亚硝胺基)-1-(3-吡啶基)-1-丁醇(NNAL)。

获取原文
获取原文并翻译 | 示例
           

摘要

The work described in this paper involves development of a high-throughput on-line microfluidic sample extraction method using capillary micro-columns packed with MIP beads coupled with tandem mass spectrometry for the analysis of urinary NNAL. The method was optimized and matrix effects were evaluated and resolved. The method enabled low sample volume (200 muL) and rapid analysis of urinary NNAL by direct injection onto the microfluidic column packed with molecularly imprinted beads engineered to NNAL. The method was validated according to the FDA bioanalytical method validation guidance. The dynamic range extended from 20.0 to 2500.0 pg/mL with a percent relative error of +/-5.9% and a run time of 7.00 min. The lower limit of quantitation was 20.0 pg/mL. The method was used for the analysis of NNAL and NNAL-Gluc concentrations in smokers' urine.
机译:本文所述的工作涉及开发一种高通量在线微流体样品提取方法,该方法使用填充了MIP珠的毛细管微柱与串联质谱联用来分析尿液NNAL。该方法已得到优化,基质效应得到评估和解决。该方法可实现低样品量(200μL),并通过直接注射到装有工程改造为NNAL的分子印迹珠的微流体柱上来快速分析尿NNAL。该方法已根据FDA生物分析方法验证指南进行了验证。动态范围从20.0 pg / mL扩展到2500.0 pg / mL,相对误差百分比为+/- 5.9%,运行时间为7.00分钟。定量下限为20.0 pg / mL。该方法用于分析吸烟者尿液中的NNAL和NNAL-Gluc浓度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号